Your browser doesn't support javascript.
loading
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.
See, Andrew W; Bowden, Patrick; Wells, Geoffrey; Appu, Sree; Lawrentschuk, Nathan; Liodakis, Peter; Pandeli, Chloe; Aarons, Yolanda; Smyth, Lloyd M L; McKenzie, Dean P.
Afiliação
  • See AW; Icon Cancer Centre, Richmond, Australia. Andrew.See@icon.team.
  • Bowden P; Icon Cancer Centre, Richmond, Australia.
  • Wells G; Urology Department, Eastern Health, Box Hill Hospital, Box Hill, Australia.
  • Appu S; Department of Surgery, Monash University, Melbourne, Australia.
  • Lawrentschuk N; Cabrini Health, Malvern, Australia.
  • Liodakis P; Department of Urology, Austin Health, Heidelberg, Australia.
  • Pandeli C; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Aarons Y; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.
  • Smyth LML; Department of Surgery, University of Melbourne, Melbourne, Australia.
  • McKenzie DP; EJ Whitten Centre for Prostate Cancer Research, Epworth Healthcare, Melbourne, Australia.
Radiat Oncol ; 17(1): 131, 2022 Jul 25.
Article em En | MEDLINE | ID: mdl-35879722
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia de Intensidade Modulada Tipo de estudo: Observational_studies Limite: Humans / Male País como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia de Intensidade Modulada Tipo de estudo: Observational_studies Limite: Humans / Male País como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article